Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
116 studies found for:    Open Studies | "Nephritis"
Show Display Options
Rank Status Study
21 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
22 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
23 Recruiting Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis
Condition: Henoch Schönlein Nephritis
Intervention: Other: kidney biopsy
24 Unknown  Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tamibarotene
25 Recruiting OMS721 Treatment of Steroid-Dependent Glomerulopathies
Conditions: Steroid-Dependent IgAN;   Lupus Nephritis;   MN;   C3G
Intervention: Biological: OMS721
26 Recruiting Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease
Conditions: Nephritis, Hereditary;   Alport Syndrome;   Alport Syndrome, Autosomal Dominant;   Alport Syndrome, Autosomal Recessive;   Hematuria-Nephropathy-Deafness Syndrome
Intervention:
27 Recruiting The Research of Standard Diagnosis and Treatment for HSPN in Children
Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone;   Drug: Cyclophosphamide(CTX);   Drug: Mycophenolate mofetil(MMF);   Drug: Leflunomide(LEF);   Drug: Angiotensin-converting enzyme inhibitor(ACEI);   Drug: Methylprednisolone
28 Recruiting The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone;   Drug: ACEI
29 Unknown  The Effect of Calcitriol on Progress and Activity of Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: calcitriol;   Drug: placebo
30 Recruiting The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
Condition: Lupus Nephritis
Intervention: Drug: mycophenolic acid
31 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
32 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
33 Recruiting Immune System Related Kidney Disease
Conditions: Glomerulonephritis;   Lupus Nephritis;   Membranous Glomerulonephritis;   Autoimmune Disease;   Nephrotic Syndrome
Intervention:
34 Recruiting CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
35 Unknown  Cyclophosphamide in Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Intervention:
36 Recruiting Prediction of Outcome of Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Intervention: Other: Serum collection
37 Recruiting ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Condition: SLE Glomerulonephritis Syndrome, WHO Class V
Intervention: Drug: Acthar gel
38 Recruiting Alport Syndrome Treatments and Outcomes Registry
Condition: Alport Syndrome
Intervention:
39 Recruiting Study of Weekly RG-012 Injections in Patients With Alport Syndrome
Condition: Alport Syndrome
Interventions: Drug: RG-012;   Drug: Placebo
40 Recruiting European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
Conditions: Alport Syndrome;   Hereditary Kidney Disease;   Pediatric Kidney Disease;   Thin Basement Membrane Disease;   Familial Benign Hematuria
Interventions: Drug: ACE-inhibitor;   Drug: AT1-inhibitor;   Drug: HMG-Coenzyme inhibitor (statin);   Drug: Spironolactone;   Drug: Paricalcitol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years